Literature DB >> 2994225

Human apolipoprotein B: structure of carboxyl-terminal domains, sites of gene expression, and chromosomal localization.

T J Knott, S C Rall, T L Innerarity, S F Jacobson, M S Urdea, B Levy-Wilson, L M Powell, R J Pease, R Eddy, H Nakai.   

Abstract

Apolipoprotein (apo-) B is the ligand responsible for the receptor-mediated catabolism of low density lipoproteins, the principal cholesterol-transporting lipoproteins in plasma. The primary structure of the carboxyl-terminal 30 percent (1455 amino acids) of human apo-B (apo-B100) has been deduced from the nucleotide sequence of complementary DNA. Portions of the protein structure that may relate to its receptor binding function and lipid binding properties have been identified. The apo-B100 messenger RNA is about 19 kilobases in length. The apo-B100 gene is expressed primarily in liver and, to a lesser extent, in small intestine, but in no other tissues. The gene for apo-B100 is located in the p24 region (near the tip of the short arm) of chromosome 2.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2994225     DOI: 10.1126/science.2994225

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  58 in total

1.  Apolipoprotein B genetic variants modify the response to fenofibrate: a GOLDN study.

Authors:  Mary K Wojczynski; Guimin Gao; Ingrid Borecki; Paul N Hopkins; Laurence Parnell; Chao-Qiang Lai; Jose M Ordovas; B Hong Chung; Donna K Arnett
Journal:  J Lipid Res       Date:  2010-08-19       Impact factor: 5.922

2.  A single chicken oocyte plasma membrane protein mediates uptake of very low density lipoprotein and vitellogenin.

Authors:  S Stifani; D L Barber; J Nimpf; W J Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

3.  Reconstituting initial events during the assembly of apolipoprotein B-containing lipoproteins in a cell-free system.

Authors:  Z Gordon Jiang; Yuhang Liu; M Mahmood Hussain; David Atkinson; C James McKnight
Journal:  J Mol Biol       Date:  2008-09-12       Impact factor: 5.469

4.  Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents.

Authors:  Gang Zheng; Juan Chen; Hui Li; Jerry D Glickson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-23       Impact factor: 11.205

5.  Apolipoproteins AI/B/E gene polymorphism and their plasma levels in patients with coronary artery disease in a tertiary care-center of Eastern India.

Authors:  Santanu Biswas; Pradip K Ghoshal; Bhubaneswar Halder; Kajal Ganguly; Arup DasBiswas; Nripendranath Mandal
Journal:  Indian Heart J       Date:  2013-10-30

6.  Introduction to recombinant DNA.

Authors:  J Scott
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

7.  Hepatocyte nuclear factor 1 and C/EBP are essential for the activity of the human apolipoprotein B gene second-intron enhancer.

Authors:  A R Brooks; B Levy-Wilson
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

8.  The epidermal growth factor homology domain of the LDL receptor drives lipoprotein release through an allosteric mechanism involving H190, H562, and H586.

Authors:  Zhenze Zhao; Peter Michaely
Journal:  J Biol Chem       Date:  2008-08-03       Impact factor: 5.157

9.  Precursor-product relationship between vitellogenin and the yolk proteins as derived from the complete sequence of a Xenopus vitellogenin gene.

Authors:  S Gerber-Huber; D Nardelli; J A Haefliger; D N Cooper; F Givel; J E Germond; J Engel; N M Green; W Wahli
Journal:  Nucleic Acids Res       Date:  1987-06-25       Impact factor: 16.971

10.  Genetic association study of selected candidate genes (ApoB, LPL, Leptin) and telomere length in obese and hypertensive individuals.

Authors:  Birajalaxmi Das; Nilambari Pawar; Divyalakshmi Saini; M Seshadri
Journal:  BMC Med Genet       Date:  2009-09-22       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.